Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Name: Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Published: 2025
License: Public Domain

Novartis Pharmaceuticals · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

chronic urticaria (cu): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (csu), remibrutinib, lou064, chronic urticaria, cindu, csu, symptomatic dermographism, cold urticaria, cholinergic urticaria, heat urticaria, solar urticaria, delayed pressure urticaria

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1007002
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.